Celanese
$43.90
▼ -1.83%
−$0.82
NYSE · Basic Materials · Chemicals
· price updated 9h ago
CE · NYSE · Basic Materials · Chemicals · price updated 9h ago
$43.90
▼ -1.83% · −$0.82 today
AI research · $43.90
Operating record
Capital structure
Valuation
Forward P/E
Price against expected earnings
Favorable · 46% below Sector avg · favorable
6.92x
Price / sales
Value assigned to each sales dollar
Strong · Under 3x annual sales
0.52x
Price / FCF
Price against free cash generation
Strong · Under 20x free cash flow
5.59x
EV / EBITDA
Operating value including debt
Rich · Above 22x EBITDA
236.05x
Quality
ROIC
Return earned on invested capital
Weak · Below 8% return on capital
5.4%
ROE
Profit generated from shareholder equity
Needs attention · Among weakest in sector
-21.1%
Debt / equity
Balance-sheet leverage
Needs attention · Among weakest in sector
2.88x
Current ratio
Short-term assets against liabilities
Reasonable · Assets still cover near-term liabilities
1.38x
Selected financial data sourced from StockAnalysis and refreshed weekly. Figures may be delayed and are for research context, not investment advice.
| company | mkt cap | P/E | rev growth | score |
|---|---|---|---|---|
| $4.90B | - | -5.5% | 61 | |
| $98.74B | 11.8 | +25.2% | 83 | |
| $9.47B | 20.3 | +66.3% | 81 | |
| $4.43B | 13.4 | +7.5% | 76 | |
| $90.03B | 30.8 | +0.2% | 70 |
US stock research
Celanese tracked in the US core universe. CE was -1.8% in the latest available session at $43.90. Its reported market value was $4.90B with a trailing P/E of 0.0. Latest reported revenue was $9.49B, changing -5.5% year over year, with $-1.14B in net income.
Market snapshot updated Aug 3, 2026, 7:59 PM UTC.